Start: September 21, 2023 12:00 pm
End: September 21, 2023 1:00 pm
Host: ATA Therapeutics Lifecycle Special Interest Group
Register Here      
Bioethical Considerations in Telehealth Enabled Clinical Trials, An Interdisciplinary Discussion
The decentralized nature of telehealth enabled trials creates a different set of regulatory and ethical considerations compared to traditional, centralized trials. This expert panel will discuss these considerations from four different perspectives: clinical researcher, legal, bioethics professional, and participant/patient.
Speakers:
- Moderator: Tufia Haddad, MD – Co-Chair, ATA Therapeutics Lifecycle SIG and Chair, Practice Innovation and Platform, Mayo Clinic Comprehensive Cancer Center; Medical Director of Care at Home, Center for Digital Health, Mayo Clinic
- Michelle McGowan, MD, Professor of Biomedical Ethics
- Shaalan Beg, MD – Vice President, Oncology, Science 37
- Kyle Faget – Partner and Co-Chair, Health Care Practice Group, Foley & Lardner
- Paul Melmeyer – VP, Public Policy and Advocacy, Muscular Dystrophy Association